Leveraging artificial intelligence for decision-making in pediatric progressive and refractory solid tumors
{{output}}
Pediatric patients with progressive and refractory solid tumors face a challenging prognosis. Despite advancements in treatments like immunotherapy and targeted therapy, survival rates remain low for certain tumor types. Decision-making in these complex cases ... ...
